Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2017
Reporting Period: Quarter ended September 30, 2017
Context: The registrant is an emerging growth company. This filing serves to announce financial results for the third quarter of 2017 via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes regarding financial performance or operations are detailed in the text of this filing. The document solely indicates that results for the quarter ended September 30, 2017, were announced on November 8, 2017.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It notes that the information in the referenced press release is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by specific reference in another filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2017) for actual revenue, net income, and cash flow figures.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm whether the press release contains updated guidance or material risk disclosures not present in this cover sheet.